Medical College of Georgia Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
1999
NCT00005623
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

MBCCOP - Medical College of Georgia Cancer Center | Medical College of Georgia | Medical College of Georgia School of Dentistry

Active Ingredients

Drugs in Phase 3 Trials (1)

cyproviron (1 trial)

Drugs in Other Trials (1)

metronidazole (flagyl) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hot Flashes (Phase 3)

Prostatic Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2